India's Chemical Sector to Gain from China's Structural Shifts: Emkay Research
India's specialty chemicals sector is poised for a favorable medium-term outlook, driven by China's structural shift away from excessive competition towards sustainable, value-driven growth, according to Emkay Research. Reforms like stricter capacity approvals and VAT cuts in China will enhance pricing power for Indian bulk chemical manufacturers. While some specialty sub-segments may face near-term pressure, geopolitical factors and global supply chain recalibration solidify India's position as a key beneficiary in the evolving chemical landscape.
A recent report by Emkay Research indicates a promising medium-term outlook for India's specialty chemicals sector, largely due to significant structural transformations underway in China. Following an extensive on-ground assessment, the brokerage highlights China's intensifying push toward 'anti-involution,' a strategic move away from intense competition and irrational pricing toward more sustainable, value-driven growth. These reforms are described as thoughtful and structural, moving beyond cyclical trends seen previously. Specific changes include stricter capacity approvals, VAT rebate cuts, and a broader policy shift focusing on higher value-added products. This recalibration in China is expected to foster a supportive environment for Indian bulk chemical manufacturers, leading to global supply tightness and firmer pricing as China rationalizes capacity and prioritizes margins. Additionally, geopolitical events, such as the Middle East conflict, have accelerated pricing adjustments, allowing Chinese manufacturers to implement price hikes from previously breakeven levels. This could establish a structurally higher base for global chemical prices, benefiting Indian exporters and domestic producers. However, the report notes a more nuanced outlook for certain specialty chemical sub-segments, particularly agrochem intermediates, which may face near-term margin pressure due to capacity additions and price corrections in China. Despite these specific challenges, the broader structural narrative remains intact, with India gaining from supply chain diversification, regulatory advantages, and improved competitiveness. Overall, Emkay's assessment underscores a cyclical recovery layered on top of structural tailwinds, positioning Indian manufacturers as key beneficiaries in the evolving global chemical sector as China transitions towards disciplined growth.
